Published in Neural Regen Res on June 25, 2012
Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev (2001) 36.00
The molecular biology of chronic myeloid leukemia. Blood (2000) 5.22
Opioid receptors. Annu Rev Biochem (2004) 2.71
Arrangement of rhodopsin transmembrane alpha-helices. Nature (1997) 2.10
Molecular cloning of a rat kappa opioid receptor reveals sequence similarities to the mu and delta opioid receptors. Biochem J (1993) 1.34
Computational methods for the structural alignment of molecules. J Comput Aided Mol Des (2000) 1.25
Thienopyrimidine ureas as novel and potent multitargeted receptor tyrosine kinase inhibitors. J Med Chem (2005) 1.04
Fast 3D molecular superposition and similarity search in databases of flexible molecules. J Comput Aided Mol Des (2003) 0.96
Pharmacophore, drug metabolism, and pharmacokinetics models on non-peptide AT1, AT2, and AT1/AT2 angiotensin II receptor antagonists. J Med Chem (2005) 0.94
FLASHFLOOD: a 3D field-based similarity search and alignment method for flexible molecules. J Comput Aided Mol Des (2001) 0.91
Selectivity fields: comparative molecular field analysis (CoMFA) of the glycine/NMDA and AMPA receptors. J Med Chem (2003) 0.90
Influences of the size and hydroxyl number of fullerenes/fullerenols on their interactions with proteins. J Nanosci Nanotechnol (2010) 0.90
Synthesis study on marmycin A: preparation of the C3'-desmethyl analogues. J Org Chem (2009) 0.88
Neuroprotection of ginsenoside Re in cerebral ischemia-reperfusion injury in rats. J Asian Nat Prod Res (2008) 0.88
A novel shape-feature based approach to virtual library screening. J Chem Inf Comput Sci (2002) 0.88
A comparison of the pharmacophore identification programs: Catalyst, DISCO and GASP. J Comput Aided Mol Des (2003) 0.87
Structure-activity relationship study of some triazolinone based compounds with antagonistic balanced activity on angiotensin II receptor subtypes AT1 and AT2. A three-dimensional quantitative structure-activity relationship investigation. Arzneimittelforschung (2005) 0.79
3D-QSAR study of hallucinogenic phenylalkylamines by using CoMFA approach. J Comput Aided Mol Des (2007) 0.79
First and convergent synthesis of hybrid sulfonophosphinopeptides. Org Lett (2009) 0.78
3D-QSAR study with pharmacophore-based molecular alignment of hydroxamic acid-related phosphinates that are aminopeptidase N inhibitors. Drug Discov Ther (2008) 0.78